Browsing by Author "Rij, C.M. van"

Now showing items 1-15 of 15

Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer
Kok, Judith L.; Teepen, J.C.; Pal, Helena J. van der; Leeuwen, F.E. van; Tissing, W.J.; Neggers, Sebastian J. C. M. M.; Loonen, J.J. ; Hoeben, B.A.W. ; Jongmans, M.C.J. ; Kremer, L.C.; Ronckers, C.; Rij, C.M. van ; Tersteeg, R.J.H.A. et al. sine al.
2019, Article / Letter to editor (Jama Oncology, vol. 5, iss. 5, (2019), pp. 671-680)
(Pre)targeting of prostate cancer
Rij, C.M. van
2016, Dissertation
Induction chemotherapy followed by surgery for advanced oesophageal cancer
Toxopeus, E.L.; Talman, S.; Gaast, A. van der; Spaander, V.M.; Rij, C.M. van ; Krak, N.C.; Biermann, K.; Tilanus, H.W.; Mathijssen, R.H.; Lanschot, J.J. van; Wijnhoven, B.P. et al. sine al.
2015, Article / Letter to editor (European Journal of Surgical Oncology, vol. 41, iss. 3, (2015), pp. 323-332)
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol
Noordman, B.J.; Shapiro, J.; Spaander, M.C.W.; Krishnadath, K.K.; Laarhoven, H.W. van ; Berge Henegouwen, M.I. van; Nieuwenhuijzen, G.A.; Hillegersberg, R. van; Sosef, M.N.; Steyerberg, E.W.; Wijnhoven, B.P.; Lanschot, J.J. van; Rij, C.M. van ; Siersema, P.D. ; et al. et al. sine al.
2015, Article / Letter to editor (JMIR Research Protocols, vol. 4, iss. 2, (2015), pp. e79)
Pretargeted immunoPET of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody in mice with PC3 xenografts
Rij, C.M. van ; Frielink, C. ; Goldenberg, D.M.; Sharkey, R.M.; Franssen, G.M. ; Lutje, S.; McBride, W.J.; Oyen, W.J.G. ; Boerman, O.C.
2015, Article / Letter to editor (Molecular Imaging and Biology, vol. 17, iss. 1, (2015), pp. 94-101)
Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts
Lutje, S.; Rij, C.M. van ; Franssen, G.M. ; Fracasso, G.; Helfrich, W.; Eek, A. ; Oyen, W.J.G. ; Colombatti, M.; Boerman, O.C.
2015, Article / Letter to editor (Contrast Media and Molecular Imaging, vol. 10, iss. 1, (2015), pp. 28-36)
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer
Lütje, S.; Rijpkema, M.J.P. ; Goldenberg, D.M.; Rij, C.M. van ; Sharkey, R.M.; McBride, W.J.; Franssen, G.M. ; Frielink, C. ; Helfrich, W.; Oyen, W.J.G. ; Boerman, O.C. et al. sine al.
2014, Article / Letter to editor (Cancer Research, vol. 74, iss. 21, (2014), pp. 6216-6223)
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2$$Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide
Rij, C.M. van ; Frielink, C. ; Goldenberg, D.M.; Sharkey, R.M.; Lutje, S.; McBride, W.J.; Oyen, W.J. ; Boerman, O.C.
2014, Article / Letter to editor (Cancer Biotherapy & Radiopharmaceuticals, vol. 29, iss. 8, (2014), pp. 323-329)
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody
Rij, C.M. van ; Lütje, S.; Frielink, C. ; Sharkey, R.M.; Goldenberg, D.M.; Franssen, G.M. ; McBride, W.J.; Rossi, E.A.; Oyen, W.J. ; Boerman, O.C.
2013, Article / Letter to editor (European Journal of Nuclear Medicine and Molecular Imaging, vol. 40, iss. 9, (2013), pp. 1377-1383)
Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors
van Waas, M.; Neggers, S.J.; Raat, H.; Rij, C.M. van ; Pieters, R.; van den Heuvel-Eibrink, M.M.
2012, Article / Letter to editor (PLoS One, vol. 7, iss. 12, (2012), article e52237)
Prospects in radionuclide imaging of prostate cancer.
Lutje, S.; Boerman, O.C. ; Rij, C.M. van ; Sedelaar, J.P.M. ; Helfrich, W.; Oyen, W.J.G. ; Mulders, P.F.A.
2012, Article / Letter to editor (Prostate, vol. 72, iss. 11, (2012), pp. 1262-1272)
Preoperative chemoradiotherapy for esophageal or junctional cancer.
Hagen, P. van; Hulshof, M.C.C.; Lanschot, J.J. van; Steyerberg, E.W.; Berge Henegouwen, M.I. van; Wijnhoven, B.P.; Richel, D.J.; Nieuwenhuijzen, G.A.; Hospers, G.A.; Bonenkamp, J.J. ; Cuesta, M.A.; Blaisse, R.J.; Busch, O.R.; Kate, F.J. ten; Creemers, G.J.; Punt, C.J.A. ; Plukker, J.T.; Verheul, H.M.; Spillenaar Bilgen, E.J.; Dekken, H. van; Sangen, M.J. van der; Rozema, T.; Biermann, K.; Beukema, J.C.; Piet, A.H.; Rij, C.M. van ; Reinders, J.G.; Tilanus, H.W.; Gaast, A. van der; Krieken, J.H. van ; et al. et al. sine al.
2012, Article / Letter to editor (The New England Journal of Medicine, vol. 366, iss. 22, (2012), pp. 2074-2084)
A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers
Sharkey, R.M.; Rij, C.M. van ; Karacay, H.; Rossi, E.A.; Frielink, C. ; Regino, C.; Cardillo, T.M.; McBride, W.J.; Chang, C.H.; Boerman, O.C. ; Goldenberg, D.M. et al. sine al.
2012, Article / Letter to editor (The Journal of Nuclear Medicine (1978), vol. 53, iss. 10, (2012), pp. 1625-1632)
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody
Rij, C.M. van ; Sharkey, R.M.; Goldenberg, D.M.; Frielink, C. ; Molkenboer-Kuenen, J.D.M. ; Franssen, G.M. ; Weerden, W.M. van; Oyen, W.J.G. ; Boerman, O.C.
2011, Article / Letter to editor (The Journal of Nuclear Medicine (1978), vol. 52, iss. 10, (2011), pp. 1601-1607)
Productie en klinische toepassingen van [15O]gelabelde gassen.
Rij, C.M. van ; Sturkenboom, M.C.; Luurtsema, G.; Franssen, E.J.F.
2008, Article / Letter to editor (Pharmaceutisch Weekblad, vol. 2, iss. 12, (2008), pp. 69-71)

Now showing items 1-15 of 15

Radboud Repository

Browsing by Author "Rij, C.M. van"

Search Repository

Browse

All of Repository